29 Feb, 2024 09:20 AM
-- First Pancreatic Cancer participant dosed at the Montefiore Medical Center, New York, USA
-- Phase I study of 9 participants is designed to assess the safety and dosimetry of RAD 301
-- A total...read more
21 Feb, 2024 09:47 AM
Sydney, Australia – 21 February 2024 – Radiopharm Theranostics Limited (ASX:RAD), a developer of a world class platform of radiopharmaceutical products for both diagnostic and therapeuti...read more
08 Feb, 2024 10:13 AM
Rural Funds Management Limited (RFM), the responsible entity of Rural Funds Group (RFF), provides an update on independent valuations arranged for the six months ended 31 December 2023 (1H24). ...read more
06 Feb, 2024 12:02 PM
Further to Radiopharm Theranostics Limited (ASX:RAD) (Radiopharm or Company) announcement earlier today, the issue of shares under the Share Subscription Agreement is amended as below and attached.
...read more
06 Feb, 2024 10:09 AM
-- Up to A$12.5 million investment by US institutional investor, Lind Partners.
-- Under a Share Subscription Agreement, RAD will receive A$1.2 million, with up to a further A$11.3 million in fundi...read more
24 Jan, 2024 10:38 AM
On 31 October 2023, Radiopharm Theranostics Limited (ASX:RAD) (Radiopharm or Company) announced the details of a non-renounceable entitlement offer (Entitlement Offer) to raise approximate...read more
27 Dec, 2023 09:15 AM
-- Ethics Committee approval received from Hollywood Private Hospital in Perth, WA
-- Patient recruitment to commence shortly
-- Phase 1 study in 21 patients designed to evaluate the safety and ef...read more